Friday 3 July 2015

Too few men with low-risk prostate cancers get "watch and wait" approach

A new report indicates that the majority of U.S. men with low-risk prostate cancer are receiving treatment in lieu of active surveillance.  According to study co-author Dr. Hui Zhu, chief of urology at the Louis Stokes Cleveland VA Medical Center in Ohio, active surveillance, "the careful monitoring of prostate cancer for progression of the cancer that would indicate a need for treatment", may be gaining acceptance among urologists and patients, although it has been met with controversy.  Zhu's study stated that older men over 60, as well as those patients without insurance were more likely to have active surveillance.

To read more about this study, click here

No comments:

Post a Comment